LCS
NPTN

Levin Capital Strategies’s NEOPHOTONICS CORP NPTN Stock Holding History

Levin Capital Strategies’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60,000
Closed -$545K – 425
2020
Q4 		$545K Buy
+60,000
New +$464K 0.06% 139
2019
Q3 		– Sell
-49,000
Closed -$205K – 230
2019
Q2 		$205K Buy
49,000
+14,000
+40% +$73.8K 0.02% 181
2019
Q1 		$220K Buy
+35,000
New +$245K 0.02% 164
2018
Q3 		– Sell
-10,000
Closed -$62K – 313
2018
Q2 		$62K Sell
10,000
-10,000
-50% -$63.6K ﹤0.01% 277
2018
Q1 		$137K Buy
+20,000
New +$127K ﹤0.01% 285

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Levin Capital Strategies's NPTN Position: Q1 2021 in Review

Levin Capital Strategies sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 60,000 shares — an estimated $545K sold.

Levin Capital Strategies first reported a position in NPTN in Q1 2018 and held it in 5 quarters. The position peaked at $545K in Q4 2020. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Levin Capital Strategies reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Levin Capital Strategies sold 60,000 NEOPHOTONICS CORP shares in Q1 2021, an estimated $545K.
  • Levin Capital Strategies first reported a position in NEOPHOTONICS CORP in Q1 2018 and held it in 5 quarters.
  • Levin Capital Strategies's NEOPHOTONICS CORP position peaked at $545K in Q4 2020.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Levin Capital Strategies's 13F filing for Q1 2021, filed 5 May 2021.